Effect and mechanism of GLP
2 T2DM causes changes in cognitive function 2.1 Cognitive impairment in T2DM: stages and risk factors In individuals with T2DM, cognitive functioning undergoes distinct stages of impairment, ranging from diabetes-associated cognitive decrements to MCI and dementia ( Biessels and Despa, 2018 ; Koekkoek et al., 2015 ). Numerous studies emphasize that diabetes independently poses a risk for ...
Results from extant studies indicate that type 2 diabetes mellitus (T2DM) is associated with decreased cognitive function and increased risk for dementia, notably Alzheimer's Disease (AD). Herein, we aimed to evaluate the effect of glucacon-like peptide-1 receptor agonists ( GLP-1 RAs) on cognitive measures in persons with cognitive impairment and T2DM from available systematic reviews and meta ...
Effect and mechanism of GLP

Abstract Background Diabetes mellitus (DM) is a metabolic disorder associated with cognitive impairment. Glucagon-like peptide-1 ( GLP-1 ) and its receptor ( GLP -1R) have shown neuroprotective effects. Scope of review This review explores the impact of DM on cognitive function . Diabetes-related cognitive impairment is divided into three stages: diabetes-associated cognitive decrements, mild ...
Useful Notes on Glp-1 Analogs And Cognitive Function In Prediabetic Individuals
The available data suggest that the use of GLP-1 medicines exhibits an acceptable safety profile in most individuals with neuropsychiatric disorders. Here, we review recent clinical evidence and ongoing trials exploring the efficacy and safety of GLP-1 medicines across a broad range of neurological conditions.

This particular example perfectly highlights why Glp 1 Analogs And Cognitive Function In Prediabetic Individuals is so captivating.
Glucagon-like peptide 1 ( GLP-1 ) was discovered as an insulinotropic gut hormone, suggesting a physiological role as an incretin hormone, i.e., being responsible, in part, for the higher insulin ...
Exploring the Role of GLP
GLP-1 receptor agonists ( GLP -1RAs) are synthetic analogs of the endogenous GLP-1 hormone [10]. They are engineered to avoid breakdown by degradation by dipeptidyl peptidase-4 (DPP-4) and exhibit longer half-lives, enabling sustained receptor activation [10]. GLP -1RAs have become an effective treatment for type 2 diabetes mellitus (T2DM) due to their capacity to improve glycemic control through ...

Liraglutide is a glucagon-like peptide-1 ( GLP-1 ) analogue licensed for the treatment of type 2 diabetes mellitus (T2DM). Preclinical evidence in transgenic models of Alzheimer's disease suggests that liraglutide exerts neuroprotective effects by reducing amyloid oligomers, normalising synaptic plasticity and cerebral glucose uptake, and ...
The Role of Glucagon
This population-based cohort study examines the association of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors with the risk of Alzheimer disease and related dementias in patients with type 2 diabetes.